Rep. Salazar bought Merck shares on Aug. 19 and has not sold them; the story gives attention but no company-level announcement or financial change.
Merck was bought by Rep. Salazar on Aug. 19, the same day Moderna announced a Phase 3 melanoma vaccine using Merck’s Keytruda. The story shows attention but no Merck announcement or financial data. The trade size and the congresswoman's many other trades mean this report does not change how we read Merck today.
The story ties Moderna to a successful Phase 3 melanoma vaccine that uses Merck’s Keytruda, which is positive news for Moderna’s clinical progress.
A small disclosed buy of SpaceX shares by the congresswoman signals personal belief but does not change SpaceX’s business facts.
Follow Merck & Co. Inc. (MRK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MRK